Amendment No.1 to Joint Research, Development and License Agreement Year 2000 ConformityJoint Research, Development and License Agreement • August 6th, 2004 • Cephalon Inc • Pharmaceutical preparations
This letter is to confirm our understanding concerning an amendment to be made with respect to the Joint Research, Development and License Agreement dated May 28, 1999 (the “Agreement”), between Cephalon, Inc. (“Cephalon”) and H. Lundbeck A/S (“Lundbeck”). All terms not otherwise defined herein are used as defined in the Agreement. The purpose of this amendment is to address Year 2000 compliance as it relates to the computer systems and programs in use by Lundbeck and Cephalon which are required to perform any and all services related to the Agreement.
Amendment No.2 To Joint Research, Development and License Agreement dated May 28, 1999 made between Cephalon Inc. West Chester Pennsylvania 19380-4245 andJoint Research, Development and License Agreement • November 3rd, 2004 • Cephalon Inc • Pharmaceutical preparations
March 16, 2000Joint Research, Development and License Agreement • November 3rd, 2004 • Cephalon Inc • Pharmaceutical preparations
This will serve to clarify certain aspects of the Joint Research, Development and License Agreement between Cephalon, Inc (“Cephalon”) and H Lundbeck A/S (“Lundbeck”) dated May 28, 1999 (the “Agreement”). All terms and conditions not otherwise defined or modified herein shall remain in full force and effect as set forth In the Agreement.
Amendment No.3 To Joint Research, Development and License Agreement dated May 28, 1999 made between Cephalon Inc. West Chester Pennsylvania 19380-4245 andJoint Research, Development and License Agreement • August 6th, 2004 • Cephalon Inc • Pharmaceutical preparations
WITNESSETH:Joint Research, Development and License Agreement • August 16th, 1999 • Cephalon Inc • Pharmaceutical preparations
